Myeloma-associated systemic amyloidosis presenting as chronic paronychia and palmodigital erythematous swelling and induration of the hands

Journal of the American Academy of Dermatology

Volumn 42, Issue 2 II, 2000, Pages 339-342

  Ahmed, Iftikhar ^a,b   Cronk, Julie S ^a   Crutchfield III, Charles E ^a   Dahl, Mark V ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MELPHALAN; PREDNISONE;

ADULT; AMYLOIDOSIS; ARTICLE; CASE REPORT; CHRONIC DISEASE; EARLY DIAGNOSIS; GAMMOPATHY; HUMAN; INFLAMMATORY CELL; MALE; MYELOMA; PARONYCHIA; PRIORITY JOURNAL; SURVIVAL;

EID: 0033942375     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0190-9622(00)90107-5     Document Type: Article

References (22)

1. Wong CK, Wang WJ. Systemic amyloidosis: a report of 19 cases. Dermatol 1994;189:47-51.
2. Lee DD, Huang CY, Wong CK. Dermatopathologic findings in 20 cases of systemic amyloidosis. Am J Dermatopathol 1998;20: 438-42.
3. Barlogie B, Alexanian R, Jagannath S. Plasma cell dyscrasias. JAMA 1992;268:2946-51.
4. Piette WW. Myeloma, pararoteinemias, and the skin. Med Clin North Am 1986;70:155-76.
5. Ratz JL, Bailin PL. Cuatneous amyloidosis. J Am Acad Dermatol 1981;4:21-6.
6. Wong CK. Mucocutaneous manifestations in systemic amyloidosis. Clin Dermatol 1990;8:7-12.
7. Dominey A, Ramsey M, Tschen J. Papulonodular lesions. Arch Dermatol 1990;126:2358.
8. Schwartz HC, Olson DJ. Amyloidosis: a rational approach to diagnosis by intraoral biopsy. Oral Surg 1975;39:837-43.
9. Kyle RA, Creipp PR. Amyloidosis (AL). Mayo Clin Proc 1983; 58:665-83.
10. Shapiro L, Kurban AK, Azhar HA. Lichen amyloidosus: A histochemical and electron microscopic study. Arch Pathol 1970; 90:499-508.
11. Yanagihara M, Mehregan AH, Mehregan DR. Staining of amyloid with cotton dyes. Arch Dermatol 1984;120:1184-5.
12. Breathnach SM, Bhogal B, Dyck RF, DeBeer FC, Black MM, Pepys MB. Immunohistochemical demonstration of amyloid P component in skin of normal subjects and patients with cutaneous amyloidosis. Br J Dermatol 1981;105:115-24.
13. Hawkins PN, Aprile C, Capri G, Vigano L, Munzone E, Gianni L, et al. Scintigraphic imaging and turnover studies with iodine-131 labelled serum amyloid P component in systemic amyloidosis. Eur J Nucl Med 1998;25:701-8.
14. Hawkins PN. Studies with radiolabelled serum amyloid P component provide evidence for turnover and regression of amyloid deposits in vivo. Clin Sci 1994;87:289-95.
15. Kyle RA, Greipp PR. Primary systemic amyloidosis: comparison of melphalan and prednisone versus placebo. Blood 1978;52: 818-27.
16. Cohen AS, Rubinow A, Anderson JJ, Skinner M, Mason JH, Libbey C, et al. Survival of patients with primary (AL) amyloidosis colchicine-treated cases from 1976 to 1983 compared with cases seen in previous years (1961-1973). Am J Med 1987;82: 1182-90.
17. Gertz MA, Kyle RA. Phase II trial of α-tocopherol (vitamin E) in the treatment of primary systemic amyloidosis. Am J Hematol 1990;34:55-8.
18. Wang WJ, Lin CS, Wong CK. Response of systemic amyloidosis to dimethylsulfoxide. J Am Acad Dermatol 1986;15:402-5.
19. Camoriano JK, Greipp PR, Bayer GK, Bowie EJ. Resolution of acquired factor X deficiency and amyloidosis with melphalan and prednisone therapy. N Eng J Med 1987;316:1133-5.
20. Gertz MA, Kyle RA. Primary systemic amyloidosis - a diagnostic primer. Mayo Clin Proc 1989;64:1505-19.
21. Kyle RA, Greipp PR, O'Fallon WM. Primary systemic amyloidosis: multivariate analysis for prognostic factors in 168 cases. Blood 1986;68:220-4.
22. Huang CY, Wang WJ, Wong CK. Skin biopsy gives the potential benefit in the diagnosis of systemic amyloidosis associated with cardiac involvement. Arch Dermatol 1998;134:643-5.